Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
JCSE01 - Joint IASLC-CSCO-CAALC Session
- 07:00 - 11:15
- 9/07/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Joint IASLC-CSCO-CAALC Session
- Track:
- Moderators:Chunxue Bai, Tony Mok, Yi-Long Wu, Qing Zhou, Nan Wu
-
+
JCSE01.01 - Breakfast and Poster Viewing
07:00 - 07:30
- Abstract
No abstract available for this presentation
-
+
JCSE01.02 - The Opportunity of Drugs Development on Immunotherapy in China
07:30 - 07:50 | Presenter: Qing Zhou
- Abstract
Loading... -
+
JCSE01.03 - Any Difference on Efficacy and Toxicity Between East and West?
07:50 - 08:10 | Presenter: Jie Hu
- Abstract
Loading... -
+
JCSE01.04 - Neo-Adjuvant Immunotherapy in Lung Cancer
08:10 - 08:30 | Presenter: Nan Wu
- Abstract
Loading... -
+
JCSE01.05 - Biomarker in Immunotherapy: Myth or Reality?
08:30 - 08:50 | Presenter: Alfredo Addeo
- Abstract
Loading... -
+
JCSE01.06 - New Era Beyond PD-1/PD-L1
08:50 - 09:10 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
JCSE01.07 - Discussion
09:10 - 09:20
- Abstract
No abstract available for this presentation
-
+
JCSE01.08 - Coffee Break and Poster Viewing
09:20 - 09:45
- Abstract
No abstract available for this presentation
-
+
JCSE01.09 - A Phase II Umbrella Study of Camrelizumab in Different PD-L1 Expression Cohorts in Pre-Treated Advanced/Metastatic Non-Small Cell Lung Cancer
09:45 - 09:55 | Presenter: Yi-Long Wu | Author(s): Cheng Huang, Yun Fan, Jifeng Feng, Hong-ming Pan, Liyan Jiang, Jin-Ji Yang, Xing-Ya Li, Xiao-Qing Liu, Jiang-Ping Xiong, Yan-Qiu Zhao, Ying Cheng, rui Ma, Jie Wang, Yi-Na Wang, Yan-Hui Liu, Dong-Mei Lin, Wei Shi, Xiang Lin
- Abstract
Loading... -
+
JCSE01.10 - Efficacy and Safety of Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Non-Small Cell Lung Cancer
09:55 - 10:05 | Presenter: Shuhang Wang | Author(s): Ning Li, Jianming Ying, Xiuli Tao, Fan Zhang, Ziran Zhao, Yun Ling, Yushun Gao, Jun Zhao, Qi Xue, Yousheng Mao, Wendong Lei, Ning Wu, Jianchun Duan, Yibo Gao, Zhijie Wang, Nan Sun, Jie Wang, Shugeng Gao, Jie He, Hui Zhou, Shuyan Wang
- Abstract
Loading... -
+
JCSE01.11 - Efficacy and Safety of Sintilimab with Anlotinib as First-Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
10:05 - 10:15 | Presenter: Baohui Han | Author(s): Tianqing Chu, Runbo Zhong, Hua Zhong, Bo Zhang, Wei Zhang, Chunlei Shi, jialin Qian, Yuchen Han
- Abstract
Loading... -
+
JCSE01.12 - Discussant Oral Abstracts
10:15 - 10:30 | Presenter: Bob T Li
- Abstract
No abstract available for this presentation
-
+
JCSE01.13 - Discussant Poster Abstracts
10:30 - 10:45 | Presenter: Shun Lu
- Abstract
No abstract available for this presentation
-
+
JCSE01.14 - Higher Prevalence of EGFR Mutations Significantly Correlates with Lower PD-L1 Expression in Chinese Lung Adenocarcinoma
10:45 - 10:45 | Presenter: Shiyue Zhang | Author(s): Shiwang Wen, Yuanzhu Jiang, Jun Guo, Xinglong Fan, Xuedong Pan, Yi Dai, Donglin Chen, Kai Wang, Xiaowei Dong
- Abstract
Loading... -
+
JCSE01.15 - Liver Metastases Predicts Poorer Prognosis in Advanced NSCLC Patients Who Receiving Nivolumab Monotherapy
10:45 - 10:45 | Presenter: Guowei Zhang | Author(s): Ruirui Cheng, Huijuan Wang, Zhiyong Ma
- Abstract
Loading... -
+
JCSE01.16 - Metastatic Lymph Nodes as High Immunogenicity Media for Perioperative Immunotherapy in Locally Advanced NSCLC
10:45 - 10:45 | Presenter: Chao Zhang | Author(s): Si-yang Liu, Jian Su, Xuan Gao, Lian-peng Chang, Yan-Fang Guan, Hai-yan Tu, Jin-Ji Yang, Xu-Chao Zhang, Wen-Zhao Zhong
- Abstract
Loading... -
+
JCSE01.17 - Modelling the Immunosuppressive Difference of SBRT and CRT by Simulating the Dose to Circulating Lymphocytes in Non-Small Cell Lung Cancer
10:45 - 10:45 | Presenter: Haihua Yang | Author(s): Yichao Shen, Yinnan Meng, Xingni Tang, Pinjun Gu, Changhui Yu, Wei Wang, Feng-Ming Spring Kong
- Abstract
Loading... -
+
JCSE01.18 - A CT-Based Radiomics Approach to Predict PD1 Inhibitor Response in Non-Small-Cell Lung Cancer
10:45 - 10:45 | Presenter: Jialei Wang | Author(s): Shengping Wang, Hui Yu, Chang Liu, Xinmin Zhao, Si Sun, Jianhua Chang, Jie Qiao, Xianghua Wu
- Abstract
Loading... -
+
JCSE01.19 - Tumor Mutation Score Is More Powerful Than Tumor Mutation Burden in Predicting Response to Immunotherapy in Non-Small Cell Lung Cancer
10:45 - 10:45 | Presenter: Yuan Li | Author(s): Zuhua Chen, Long Wu, Weiping Tao
- Abstract
Loading... -
+
JCSE01.20 - Pilot Study on the Tumor Immune Microenvironment Between Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
10:45 - 10:45 | Presenter: Qian Chu | Author(s): Wei Zhang, Xun Yuan, Xue Wang, Shanshan Huang, Jingyao Tu, Fangfang Liu, Jin Li, Jing Li, Yuan Chen
- Abstract
Loading... -
+
- Abstract
Loading... -
+
JCSE01.22 - Tumor Microenvironment Is Associated with Efficacy of PD-1/PD-L1 Inhibitors in Patients with Primary Pulmonary Lymphoepithelioma-Like Cancer
10:45 - 10:45 | Presenter: Xu-Chao Zhang | Author(s): Kai Yin, Zhi Xie, Zhi Yi Lv, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Wen-Zhao Zhong, Lin-Lin Li, Hui-Bo Feng, Wei-Bang Guo, Dan-Xia Lu, Yu Chen, Wen-Qing Yan, Yi-Long Wu
- Abstract
Loading... -
+
JCSE01.23 - Specific TP53 Mutation Subtypes as Biomarker for Response to PD-1/L1 Blockade Immunotherapy in NSCLC
10:45 - 10:45 | Presenter: Hao Sun | Author(s): Si-yang Liu, Jia Ying Zhou, Meimei Zheng, Jiao Jiao Huan, Yan Fang Guan, Rui Gao, Xin Yi, Yi-Long Wu
- Abstract
Loading... -
+
JCSE01.24 - Dynamic Changes of Plasma PD-L1 mRNA Expression Predict Response to Anti-PD-1/Anti-PD-L1 Treatment in Malignancies
10:45 - 10:45 | Presenter: Jianguo Sun | Author(s): Qiao Yang, Mingjing Chen, Jiaoyang Gu, Linpeng Zheng, Yongxin Yu, Feng Li, Luping Zhang, Kai Niu
- Abstract
Loading... -
+
JCSE01.25 - TP53/KMT2C Co-Mutation as a Novel Biomarker for Immunotherapy in Non-Small Cell Lung Cancer Patients
10:45 - 10:45 | Presenter: Qing Zhou | Author(s): Xiaoxiao Peng, Wenjing Wang, Weifeng Wang, Lin Zhang, Kai Wang, Shiyue Zhang
- Abstract
Loading... -
+
JCSE01.26 - PD-1 Inhibitor Plus Chemotherapy as 2nd/Subsequent Line Setting Demonstrate Superior Efficacy over PD-1 Inhibitor Alone in Pts of Advanced NSCLC
10:45 - 10:45 | Presenter: Shengxiang Ren | Author(s): Yiwei Liu, Fei Zhou, Tao Jiang, Chunxia Su, Xiaoxia Chen, Caicun Zhou
- Abstract
Loading... -
+
JCSE01.28 - Changes of Brain Structure in Advanced NSCLC Patients Receiving EGFR-TKIs: Dynamic Analysis Based on Series MRI Images
10:45 - 10:45 | Presenter: Chunli Luo | Author(s): Beisheng Yang, Xiaojuan Zhou, Lin Zhou, Ying Zhou, Jiang Zhu, Meijuan Huang, Feng Peng, Yongmei Liu, Yongsheng Wang, Zhiping Li, You Lu, Su Lui, Youling Gong
- Abstract
Loading...
-
+
MA09 - EGFR & MET
- 15:15 - 16:45
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Jordi Remon, Juergen Wolf
-
+
MA09.09 - Long-Term Outcomes to Tepotinib Plus Gefitinib in Patients with EGFR-Mutant NSCLC and MET Dysregulation: 18‑Month Follow-Up
16:15 - 16:20 | Presenter: Yi-Long Wu | Author(s): Ying Cheng, Jianying Zhou, Shun Lu, Yiping Zhang, Jun Zhao, Dong-Wan Kim, Ross Soo, Sang-we Kim, Hongming Pan, Yuh-Min Chen, Chih-Feng Chian, Xiaoqing Liu, Daniel SW Tan, Rolf Bruns, Josef Straub, Andreas Johne, Jürgen Scheele, Keunchil Park, James Chih-Hsin Yang
- Abstract
Loading...
-
+
MS04 - New Systemic Adjuvant/Neo-Adjuvant Strategies in Early Stage Lung Cancer: Targeted Therapy and I/O
- 15:15 - 16:45
- 9/08/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Treatment of Early Stage/Localized Disease
- Moderators:Eldsamira Mascarenhas, Jose Belda-Sanchis
-
+
MS04.01 - EGFR TKIs for Resected EGFRmut NSCLC
15:15 - 15:30 | Presenter: Yi-Long Wu
- Abstract
Loading...
-
+
EP1.14 - Targeted Therapy
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
EP1.14-49 - A Phase IIIb Open-Label Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Exploratory Biomarker Analysis
08:00 - 08:00 | Presenter: Jie Wang | Author(s): Jun Zhao, Hua Bai, Xin Wang, Yuyan Wang, Jianchun Duan, Hanxiao Chen, Zhiyi Xue, Susan Meng, Yahui Tian, Agnieszka Cseh, Dennis Chin-Lun Huang, Yi-Long Wu
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-104 - Survivals in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer Treated with First-Line Crizotinib
09:45 - 09:45 | Presenter: Yu-Er Gao | Author(s): Chang Lu, Hua-Jun Chen, Zhen Wang, Bin-Chao Wang, Xu-Chao Zhang, Chong-Rui Xu, Yi-Long Wu, Jin-Ji Yang
- Abstract
Loading... -
+
P1.01-28 - Mutational Heterogeneity Between Primary Pulmonary Cancer Lesions and Matched Brain Metastases
09:45 - 09:45 | Presenter: Linlin link Li | Author(s): Yu Chen, Hong-Xia Tian, De-Xiang Zhou, Dong Zhou, Xiao-Feng Lin, Kai Yin, Hui-Bo Feng, Wei-Bang Guo, Zhi Xie, Wen-Qing Yan, Zhi-Yi Lv, Dan-Xia Lu, Xue-Ning Yang, Yi-Long Wu, Xu-Chao Zhang
- Abstract
Loading... -
+
P1.01-61 - A Phase II Umbrella Study of Camrelizumab in Different PD-L1 Expression Cohorts in Pre-Treated Advanced/Metastatic Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Yi-Long Wu | Author(s): Cheng Huang, Yun Fan, Jifeng Feng, Hong-ming Pan, Liyan Jiang, Jin-Ji Yang, Xing-Ya Li, Xiao-Qing Liu, Jiang-Ping Xiong, Yan-Qiu Zhao, Ying Cheng, rui Ma, Jie Wang, Yi-Na Wang, Yan-Hui Liu, Dong-Mei Lin, Wei Shi, Xiang Lin
- Abstract
Loading... -
+
P1.01-81 - A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients with Lung Cancer
09:45 - 09:45 | Presenter: Wenfang Tang | Author(s): Qingyi Hou, Juntao Lin, Zhongyi Dong, Yangsi Li, Jinghua Chen, Honghong Yan, Shuxia Wang, Yi-Long Wu, Wen-Zhao Zhong
- Abstract
Loading... -
+
P1.01-82 - The Different Frequencies and Genetic Profiles of Histologic Transformation After Different EGFR-TKIs in EGFR-Mutant Adenocarcinomas
09:45 - 09:45 | Presenter: Jin Kang | Author(s): Hua-Jun Chen, Bin-Chao Wang, Zhen Wang, Xu-Chao Zhang, Xiang-Meng Li, Qiu-Mei Deng, Yi-Long Wu, Jin-Ji Yang
- Abstract
Loading... -
+
P1.01-85 - Treatment for Advanced NSCLC with EGFR Mutations and De Novo MET Amplification/Overexpression
09:45 - 09:45 | Presenter: Han-Min Wang | Author(s): Wen-feng Li, Qiu-Mei Deng, Jin Kang, Hua-Jun Chen, Zhen Wang, Qing Zhou, Chongrui Xu, Xu-Chao Zhang, Jian Su, Honghong Yan, Yi-Long Wu, Jin-Ji Yang
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-42 - Tumor Microenvironment Is Associated with Efficacy of PD-1/PD-L1 Inhibitors in Patients with Primary Pulmonary Lymphoepithelioma-Like Cancer
09:45 - 09:45 | Presenter: Xu-Chao Zhang | Author(s): Kai Yin, Zhi Xie, Zhi Yi Lv, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Wen-Zhao Zhong, Lin-Lin Li, Hui-Bo Feng, Wei-Bang Guo, Dan-Xia Lu, Yu Chen, Wen-Qing Yan, Yi-Long Wu
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-13 - EGFR Amplification Mediates Resistance to Third-Generation EGFR TKIs and in Vitro Validation of Combination Strategies to Overcome Resistance
09:45 - 09:45 | Presenter: Yi-Chen Zhang | Author(s): Qing Zhou, Zhihong Chen, Xu-Chao Zhang, Jian Su, Hao Sun, Si-yang Liu, Yi-Long Wu
- Abstract
Loading... -
+
P1.14-31 - Lack of Association Between BIM Deletion Polymorphism and Clinical Efficacy of EGFR-TKIs in NSCLC Based on NGS
09:45 - 09:45 | Presenter: Si-Yang Liu | Author(s): Wen-Feng Li, Hao Sun, Yi-Chen Zhang, Jia-Ying Zhou, Jin-Ji Yang, Yi-Long Wu
- Abstract
Loading... -
+
P1.14-39 - Acquired ALK Rearrangement in EGFR-Mutant Lung Adenocarcinoma Treated with EGFR TKIs
09:45 - 09:45 | Presenter: Qian-Yu Wang | Author(s): Rui-Lian Chen, Jin Kang, Hua-Jun Chen, Bin-Chao Wang, Zhen Wang, Qing Zhou, Yi-Long Wu, Jin-Ji Yang
- Abstract
Loading... -
+
P1.14-62 - Afatinib in EGFR TKI-Naïve Patients with EGFR Mutation-Positive NSCLC: Combined Analysis of Two Single-Arm Phase IIIb Studies
09:45 - 09:45 | Presenter: BJ Srinivasa | Author(s): Filippo De Marinis, Haiyan Tu, Konstantin Laktionov, Artem Poltoratskiy, Jun Zhao, Inna Egorova, Eng-Huat Tan, Maya Gottfried, Victor Lee, Dariusz Kowalski, Cheng-Ta Yang, Antonio Passaro, Laura Clementi, Wenbo Tang, Dennis Chin-Lun Huang, Agnieszka Cseh, Caicun Zhou, Yi-Long Wu
- Abstract
Loading...
-
+
MA11 - Immunotherapy in Special Populations and Predictive Markers
- 14:00 - 15:30
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:Frank Griesinger, Lecia Sequist
-
+
MA11.02 - KEYNOTE-042 China Study: First-Line Pembrolizumab vs Chemotherapy in Chinese Patients with Advanced NSCLC with PD-L1 TPS ≥1%
14:05 - 14:10 | Presenter: Yi-Long Wu | Author(s): Li Zhang, Yun Fan, Jianying Zhou, Li Zhang, Qing Zhou, Wei Li, ChengPing Hu, Gongyan Chen, Xin Zhang, Caicun Zhou, Thao Dang, Justina Penrod, Debra A. Kush, Yun Qin, Ben Li, Tony Mok
- Abstract
Loading...
-
+
MA13 - Going Back to the Roots!
- 14:00 - 15:30
- 9/09/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Maurice Perol, Kaoru Kubota
-
+
MA13.11 - A Randomized Phase III Study of Cisplatin-Polymeric Micelle Paclitaxel vs Cisplatin-Solvent-Based Paclitaxel in 1st Line Advanced NSCLC
15:10 - 15:15 | Presenter: Yi-Long Wu | Author(s): Baohui Han, Meiqi Shi, Haiyan Tu, Aiqin Gu, Cheng Huang, Huijuan Wang, Zhuang Yu, Xiuwen Wang, Lejie Cao, Yongqian Shu, Huaqing Wang, Runxiang Yang, Xingya Li, Jianhua Chang, Yanping Hu, Peng Shen, Yi Hu, Zhongliang Guo, Min Tao, Yiping Zhang, Xunyan Liu, Qian Sun, Xin Zhang, Zuguang Jiang, Junhui Zhao, Feng Chen, Jing Sun, Duan Li, Jinsong Zhou
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-79 - Afatinib in EGFR Mutation-Positive (EGFRm+) NSCLC Harbouring Uncommon Mutations: Experience in ‘Real-World’ Clinical Practice
10:15 - 10:15 | Presenter: Yi-Long Wu | Author(s): Wolfgang Brückl, Eckart Laack, Christopher Hoffmann, Caicun Zhou
- Abstract
Loading... -
+
P2.01-80 - Clinical Outcomes in Advanced EGFR-Mutant NSCLC Patients Treated with First-Generation EGFR TKIs Followed by Subsequent Osimertinib
10:15 - 10:15 | Presenter: Yi-Hui Yao | Author(s): Jiang-Tao Cheng, Jin Kang, Xiang-Meng Li, Hua-Jun Chen, Qing Zhou, Chongrui Xu, Xu-Chao Zhang, Jian Su, Hong-Hong Yan, Yi-Long Wu, Jin-Ji Yang
- Abstract
Loading... -
+
P2.01-88 - Molecular Alterations in Cerebrospinal Fluid Predict Clinical Outcomes of Central Nervous System Metastases in Lung Cancer
10:15 - 10:15 | Presenter: Meimei Zheng | Author(s): Yangsi Li, Benyuan Jiang, Haiyan Tu, Junyi Ye, Jin-Ji Yang, Xu-Chao Zhang, Shannon Chuai, Hao Sun, Qing Zhou, Wen-Zhao Zhong, Yi-Long Wu
- Abstract
Loading... -
+
P2.01-99 - A Phase IIIb Open-Label Study of Afatinib in EGFR TKI-Naïve Patients with EGFR Mutation-Positive NSCLC: Final Analysis
10:15 - 10:15 | Presenter: Yi-Long Wu | Author(s): Haiyan Tu, Jifeng Feng, Meiqi Shi, Jun Zhao, Yuyan Wang, Jianhua Chang, Jialei Wang, Ying Cheng, Jing Zhu, Eng-Huat Tan, Yiping Zhang, Victor Lee, Cheng-Ta Yang, Wu-Chou Su, David Chi-Leung Lam, BJ Srinivasa, Senthil Rajappa, Ching-Liang Ho, Kwok Chi Lam, Yi Hu, Shailesh Arjun Bondarde, Xiaoqing Liu, Kaimin Pang, Yahui Tian, Agnieszka Cseh, Dennis Chin-Lun Huang, Caicun Zhou
- Abstract
Loading...